Rani Jarkas — Hong Kong to be a Perfect Location for Biotechnology Firms
The vital location of Hong Kong, its robust intellectual property protection and unique role to represent as an international business and financial centre, makes it a top-notch location for biotechnology firms, said Miss Anita Chan, Director of the Hong Kong Economic and Trade Office.
Speaking at the Hong Kong Reception at BIO International Convention 2012 in Boston on June 19 (Boston time), Miss Chan mentioned that there are around 300 biotech companies in Hong Kong and the number is on the rise. Two inclusions of late are Massachusetts firms — Paexcel Corporation and Biogen Idec.
Rani Jarkas, the Chairman of Cedrus Investments, a global boutique investment firm headquartered in Hong Kong, strongly believes that the biotechnology industry has been developing firmly since the first biotech startups in the 1970s.
A high-powered delegation from Hong Kong was also present at the reception. They consisted of Hong Kong Biotechnology Organisation and Chairman and CEO of Hai Kang Life Corporation, Professor Albert Yu; Chairman of Hong Kong Science and Technology Parks Corporation, Mr Nicholas Brooke and CEO of Hong Kong Science and Technology Parks Corporation, Mr Anthony Tan. There were even some of the most distinguished industry players and exhibitors present from Hong Kong.
These top-notch players and pioneers are taking part in the convention including a Hong Kong Pavilion that displayed the potential of the biotech industry in Hong Kong and its achievements as well. The organisers of Hong Kong Pavilion are Hong Kong Biotechnology Organisation, Hong Kong Science and Technology Parks, and Hong Kong Trade Development Council.
Miss Chan indicated that Innovation and Technology is one of the six new industries that Hong Kong has clear benefits. She commented, “We are committed to developing Hong Kong as a knowledge-based economy, making Hong Kong an innovation hub in the region.”
Hong Kong doesn’t have a lack of prominent life-science researchers, including globally acclaimed geneticist Professor Tsui Lap-Chee, who’s also the Vice-Chancellor of the University of Hong Kong (HKU); chemical pathology expert, the Chinese University of Hong Kong Professor Dennis Lo; neuroscience researcher, the Hong Kong University of Science and Technology Professor Nancy Ip, and HKU Professor Yuen Kwok-yung who first reported the discovery of the agent that causes Severe Acute Respiratory Syndrome, and influenza expert Professor Malik Peiris.
“We look forward to welcoming more companies and scientists to Hong Kong”, Miss Chan Said to the conference attendees. She also urged the participants to visit Hong Kong and discover the opportunities for business, research and collaboration.
Rani Jarkas acknowledges that BIO International Convention 2012 is the largest global event for the biotechnology industry. It consists of keynotes and sessions from main policymakers, CEOs, scientists, and celebrities as well.